Skip to content

Development of portable visual naso intestinal tube indwelling system and its application in ICU severe patients

Development of portable visual naso intestinal tube indwelling system and its application in ICU severe patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075438
Enrollment
Unknown
Registered
2023-09-05
Start date
2022-01-02
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patient in severe condition

Interventions

Experimental group:Indwelling Nasal Intestinal Canal through Visualization System
Control group:Conventional treatment

Sponsors

Lishui Municipal Central Hospital, Zhejiang , China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: ? Critically ill patients in ICU, aged over 18, are expected to stay in ICU for more than 2 days. Patients with acute gastrointestinal injury grade II-IV have no contraindications to indwelling naso intestinal tube. ? The patient has stable hemodynamics, no contraindications to enteral nutrition, gastric retention or gastric dysfunction, and high risk of aspiration. It is impossible to implement enteral nutrition through nasogastric tube. Early enteral nutrition can be carried out according to the guidelines. ? The patient or the patient's family members have signed the informed consent to use this system for naso intestinal tube retention.

Exclusion criteria

Exclusion criteria: ? Contraindications of indwelling naso intestinal tube: such as severe coagulation dysfunction, intestinal obstruction, intestinal ischemia, severe abdominal distension, gastrointestinal perforation, etc. ? The patient's family members (or other legal representatives of the patient) do not agree to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
First catheterization success rate;

Secondary

MeasureTime frame
Placement time;Respiration and heart rate;Albumin, prealbumin;

Countries

China

Contacts

Public ContactTian Xin

Lishui Municipal Central Hospital

xqjywz@163.com+86 135 6761 5537

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026